Last viewed:
AVGR
Prices are updated after-hours
AVGR
|
$3.92
220
|
Health Technology
(0.0% 1d)
(9.7% 1m)
(642.6% 1y)
(0.0% 2d)
(0.0% 3d)
(-1.9% 7d)
(-43.33%
volume)
Earnings Calendar: 2022-08-09
Market Cap: $ 6,218,821
http://www.avinger.com
Sec
Filling
|
Patents
| 81 employees
(US) Avinger, Inc. manufactures catheter devices used to treat vascular diseases. It designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.
cardiologists
heart
cardiology
add to watch list
Paper trade
email alert is off
Press-releases
Avinger Reports Fourth Quarter and Full Year 2023 Results
Published: 2024-03-20
(Crawled : 00:00)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 16.77%
| O: 2.26%
H: 4.1%
C: 4.1%
year
results
Avinger to Announce Full Year 2023 Results on March 20, 2024
Published: 2024-03-12
(Crawled : 15:00)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 9.37%
| O: -2.72%
H: 0.48%
C: -3.73%
year
results
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
Published: 2024-03-07
(Crawled : 07:00)
- prnewswire.com
AVGR
|
$3.92
220
|
Health Technology
| -2.16%
| O: 11.08%
H: 0.97%
C: -19.71%
partnership
solutions
Avinger to Announce Third Quarter 2023 Results on October 26
Published: 2023-10-19
(Crawled : 13:00)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| -36.93%
| O: 2.61%
H: 0.0%
C: -6.62%
results
Avinger to Announce Second Quarter 2023 Results on July 27
Published: 2023-07-20
(Crawled : 13:00)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 302.22%
| O: 2.22%
H: 30.43%
C: 14.13%
results
Avinger Announces Presentations by Key Opinion Leaders at LINC 2023
Published: 2023-06-20
(Crawled : 14:00)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 513.56%
| O: 5.0%
H: 4.92%
C: 0.37%
Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System
Published: 2023-06-07
(Crawled : 12:20)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 505.35%
| O: -1.34%
H: 1.68%
C: -3.39%
clearance
system
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
Published: 2023-06-05
(Crawled : 13:20)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 560.58%
| O: 0.36%
H: 9.07%
C: 7.27%
device
total
Avinger to Announce First Quarter 2023 Results on May 10
Published: 2023-05-02
(Crawled : 12:20)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 699.12%
| O: 3.75%
H: 0.0%
C: -6.38%
results
Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium
Published: 2023-04-28
(Crawled : 14:00)
- biospace.com/
AVGR
|
$3.92
220
|
Health Technology
| 558.18%
| O: -7.27%
H: 5.88%
C: -4.25%
symposium
international
treatment
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount